QA: Opiant Pharmaceuticals INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385508_2020_Opiant_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001385508, Opiant Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 39,254,656
1 IntangibleAssetsNetIncludingGoodwill 14,373
2 PropertyPlantAndEquipmentNet 243,039
3 remainder_Assets 768,441
4 LiabilitiesCurrent 5,609,819
5 LiabilitiesNoncurrent 255,000
6 remainder_Liabilities -336
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,882,135
9 ResearchAndDevelopmentExpense 9,266,135
10 remainder_Expenses 10,035,282
11 remainder_Revenues 32,305,288
12 remainder_NetIncome 570,452
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 40,280,509
1 Liabilities 5,864,483
2 Expenses 31,183,552
3 Revenues 32,305,288
4 StockholdersEquity 34,416,026
5 NetIncome 1,692,188
6 ComprehensiveNetIncome 1,692,188
7 BaseVar 55,102,142
8 EconomicCapitalRatiobeforeLimitedLiability 3.33
9 EconomicCapitalRatio 3.91

Edgar->Model Mapping

Feature Distribution

Change over Time